IL102132A - History of 8-carboxamide-hexahydro-2,6-methanolquinolysin preparation and pharmaceutical preparations containing them - Google Patents
History of 8-carboxamide-hexahydro-2,6-methanolquinolysin preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL102132A IL102132A IL10213292A IL10213292A IL102132A IL 102132 A IL102132 A IL 102132A IL 10213292 A IL10213292 A IL 10213292A IL 10213292 A IL10213292 A IL 10213292A IL 102132 A IL102132 A IL 102132A
- Authority
- IL
- Israel
- Prior art keywords
- methano
- quinolizin
- compound
- octahydro
- trans
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91401550A EP0517984A1 (en) | 1991-06-11 | 1991-06-11 | Derivatives of amide analogs of certain methano bridged quinolizines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL102132A0 IL102132A0 (en) | 1993-01-14 |
| IL102132A true IL102132A (en) | 1996-10-31 |
Family
ID=8208580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10213292A IL102132A (en) | 1991-06-11 | 1992-06-08 | History of 8-carboxamide-hexahydro-2,6-methanolquinolysin preparation and pharmaceutical preparations containing them |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP0517984A1 (fi) |
| JP (1) | JP3377227B2 (fi) |
| KR (1) | KR100234926B1 (fi) |
| AT (1) | ATE214392T1 (fi) |
| AU (1) | AU649836B2 (fi) |
| CA (1) | CA2070573C (fi) |
| DE (1) | DE69232473T2 (fi) |
| DK (1) | DK0518767T3 (fi) |
| ES (1) | ES2173863T3 (fi) |
| FI (1) | FI112866B (fi) |
| HU (1) | HU212735B (fi) |
| IE (1) | IE921874A1 (fi) |
| IL (1) | IL102132A (fi) |
| NO (1) | NO305124B1 (fi) |
| NZ (1) | NZ243031A (fi) |
| PT (1) | PT518767E (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993017019A1 (en) * | 1992-02-24 | 1993-09-02 | Merrell Dow Pharmaceuticals Inc. | 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist |
| US5508287A (en) * | 1992-02-24 | 1996-04-16 | Merrell Pharmaceuticals Inc. | 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist |
| GB9214184D0 (en) * | 1992-07-03 | 1992-08-12 | Smithkline Beecham Plc | Pharmaceuticals |
| FR2765107B1 (fr) * | 1997-06-26 | 2000-03-24 | Sanofi Sa | Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil |
| CZ296282B6 (cs) | 1997-11-14 | 2006-02-15 | Akzo Nobel N. V. | Farmaceutický prostredek |
| DE69931042T2 (de) | 1998-02-27 | 2006-11-23 | The Board Of Trustees Of The University Of Illinois, Urbana | Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe |
| US7160898B2 (en) | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
| EP1448557A4 (en) | 2001-10-26 | 2005-02-02 | Univ Connecticut | HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS |
| CN101132777A (zh) | 2004-12-20 | 2008-02-27 | 科利吉姆制药公司 | 用于睡眠障碍的药物组合物 |
| WO2007081889A2 (en) | 2006-01-05 | 2007-07-19 | Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Production of dolasetron |
| CN101774971B (zh) * | 2010-02-10 | 2011-07-27 | 山东众诚药业股份有限公司 | 高纯度1-甲基吲唑-3-羧酸的生产方法 |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB219363A (en) * | 1923-03-24 | 1924-07-24 | Abraham Preston | Improvements in or in connection with bed couches |
| DE3687080T2 (de) * | 1985-04-27 | 1993-03-25 | Beecham Group Plc | Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung. |
| EP0330788A1 (en) * | 1988-03-01 | 1989-09-06 | Merrell Dow Pharmaceuticals Inc. | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia |
| GB8829079D0 (en) * | 1988-12-13 | 1989-01-25 | Beecham Group Plc | Novel compounds |
-
1991
- 1991-06-11 EP EP91401550A patent/EP0517984A1/en not_active Withdrawn
-
1992
- 1992-06-05 CA CA002070573A patent/CA2070573C/en not_active Expired - Lifetime
- 1992-06-05 AU AU18037/92A patent/AU649836B2/en not_active Expired
- 1992-06-05 NZ NZ243031A patent/NZ243031A/en not_active IP Right Cessation
- 1992-06-08 IL IL10213292A patent/IL102132A/en not_active IP Right Cessation
- 1992-06-10 NO NO922270A patent/NO305124B1/no not_active IP Right Cessation
- 1992-06-10 HU HU9201939A patent/HU212735B/hu unknown
- 1992-06-10 FI FI922695A patent/FI112866B/fi not_active IP Right Cessation
- 1992-06-10 KR KR1019920010016A patent/KR100234926B1/ko not_active IP Right Cessation
- 1992-06-11 DE DE69232473T patent/DE69232473T2/de not_active Expired - Lifetime
- 1992-06-11 JP JP17598392A patent/JP3377227B2/ja not_active Expired - Lifetime
- 1992-06-11 DK DK92401618T patent/DK0518767T3/da active
- 1992-06-11 PT PT92401618T patent/PT518767E/pt unknown
- 1992-06-11 EP EP92401618A patent/EP0518767B1/en not_active Expired - Lifetime
- 1992-06-11 AT AT92401618T patent/ATE214392T1/de active
- 1992-06-11 ES ES92401618T patent/ES2173863T3/es not_active Expired - Lifetime
- 1992-07-01 IE IE187492A patent/IE921874A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE214392T1 (de) | 2002-03-15 |
| NO922270L (no) | 1992-12-14 |
| EP0518767A3 (en) | 1993-05-05 |
| DE69232473D1 (de) | 2002-04-18 |
| FI112866B (fi) | 2004-01-30 |
| PT518767E (pt) | 2002-09-30 |
| ES2173863T3 (es) | 2002-11-01 |
| AU649836B2 (en) | 1994-06-02 |
| EP0517984A1 (en) | 1992-12-16 |
| FI922695A0 (fi) | 1992-06-10 |
| IE921874A1 (en) | 1992-12-16 |
| HU9201939D0 (en) | 1992-08-28 |
| NO922270D0 (no) | 1992-06-10 |
| FI922695A (fi) | 1992-12-12 |
| NZ243031A (en) | 1994-02-25 |
| DK0518767T3 (da) | 2002-07-01 |
| DE69232473T2 (de) | 2002-11-21 |
| JP3377227B2 (ja) | 2003-02-17 |
| EP0518767A2 (en) | 1992-12-16 |
| NO305124B1 (no) | 1999-04-06 |
| KR100234926B1 (ko) | 1999-12-15 |
| KR930000518A (ko) | 1993-01-15 |
| AU1803792A (en) | 1992-12-24 |
| IL102132A0 (en) | 1993-01-14 |
| HU212735B (en) | 1996-10-28 |
| JPH05202044A (ja) | 1993-08-10 |
| EP0518767B1 (en) | 2002-03-13 |
| CA2070573C (en) | 2003-04-15 |
| CA2070573A1 (en) | 1992-12-12 |
| HUT61549A (en) | 1993-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5011846A (en) | Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof | |
| KR100263414B1 (ko) | 티에노 [3,2-b] 피리딘 유도체 | |
| JPH054983A (ja) | イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤 | |
| US5342845A (en) | Indole derivatives and drugs | |
| AU649836B2 (en) | Derivatives of amide analogs of certain methano bridged quinolizines | |
| US5955470A (en) | Derivatives of amide analogs of certain methano bridged quinolizines | |
| US5556851A (en) | Cinnoline-3-carboxylic acid derivatives | |
| IE83573B1 (en) | Derivatives of amide analogs of certain methano bridged quinolizines | |
| JP2001512727A (ja) | ５ｈｔ−１受容体のリガンドとしてのニ環式化合物 | |
| JPH08502273A (ja) | ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式エステルまたはアミド | |
| US5262537A (en) | Derivatives of 4,5,6,7-tetrahydroimidazo-[4,5-c]pyridinyl-6-carboxylic acid | |
| WO1996034865A1 (en) | Novel heterocyclic chemistry | |
| US4424225A (en) | Thienobenzodiazepinones, pharmaceutical compositions thereof and method of use thereof | |
| US5525600A (en) | (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides | |
| US5096900A (en) | (4-piperidyl)methyl-2,3-dihydro-1h-isoindole and -2,3,4,5-tetrahydro-1h-benzazepine derivatives, their preparation and their application in therapy | |
| EP0329932B1 (en) | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments | |
| EP1053235A1 (en) | Oxazole derivatives as serotonin-1a receptor agonists | |
| JPH09512025A (ja) | ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼アンタゴニストとしての三環式誘導体 | |
| US6057340A (en) | Oxazole derivatives as serotonin-1A receptor agonists | |
| US5081128A (en) | 2,3-dihydro-1h-isoindole derivatives and their application in therapy | |
| EP0628043A1 (en) | 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist | |
| JPH05230057A (ja) | 光学活性インダゾール―３―カルボキサミド誘導体及びそれを有効成分とする制吐剤 | |
| PT89046B (pt) | Processo para a preparacao de derivados de 5,6,7,8-tetra-hidro-4h-isoxazolo {4,5-c} azepina, seus isomeros e dos seus sais de adicao de acido | |
| JPS63277676A (ja) | エルゴリン誘導体およびその酸付加塩 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| RH | Patent void | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |